adreogen

About adreogen

The startup develops topical androgen therapies that specifically target Relapse-Initiating Cells (RICs) in leukemia patients to prevent drug resistance and relapse. By focusing on these critical cells, the therapies aim to enhance patient health outcomes and improve overall treatment efficacy.

What does adreogen do?

The startup develops topical androgen therapies that specifically target Relapse-Initiating Cells (RICs) in leukemia patients to prevent drug resistance and relapse. By focusing on these critical cells, the therapies aim to enhance patient health outcomes and improve overall treatment efficacy.

Where is adreogen located?

adreogen is based in Toulouse, France.

When was adreogen founded?

adreogen was founded in 2024.

Location
Toulouse, France
Founded
2024
Employees
1 employees

Find Investable Startups and Competitors

Search thousands of startups using natural language

Start Searching

adreogen

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

The startup develops topical androgen therapies that specifically target Relapse-Initiating Cells (RICs) in leukemia patients to prevent drug resistance and relapse. By focusing on these critical cells, the therapies aim to enhance patient health outcomes and improve overall treatment efficacy.

adreogen.com200+
Founded 2024 – Toulouse, France

Funding

No funding information available.

Team (<5)

No team information available.
Want to add first party data to your startup here or get your entry removed? You can edit it yourself by logging in with your company domain.